The first commercial TIL therapy is brewing at Iovance, along with various clinical readouts which are set to come to fruition in 2023, along with the 5th TIL Therapies Summit...

Be at the forefront of the Bispecific space as it goes head to head with cell therapy to transform oncology. Among numerous innovations in cancer immunotherapy, Bispecific...

The 4th Annual Gene Therapy for Ophthalmic Disorders Summit is the industry-leading, industry-focused forum for learning how to validate novel administration routes to the eye,...

The Clinical Pathways Congress + Cancer Care Business Exchange is uniting clinical providers and business leaders to ensure cancer care solutions are delivered in a timely,...

2023 is booming with novel psychiatric R AND D and the promise of precision medicine for neuropsychiatric patients. Pipelines are gaining momentum, with notable approvals on...

Staying current with the rapid advances in laser and aesthetic skin therapy is an increasingly important challenge for physicians. Our patients' demand for such services has...

To facilitate the growing demand for better flow technology, the 4th Commercializing Flow Chemistry summit is concentrating on transforming process efficiency, emerging...

The 4th Annual Commercializing Flow Chemistry Summit is dedicated to empowering you with the tools and knowledge to revolutionize your process efficiency and leverage emerging...

Returning for its 11th year, the IMPACCT: Real World Evidence Summit 2023 will deep dive into the use of RWE for regulatory submissions and clinical trial innovation to unlock...

Amongst the latest innovations in patient-derived iPSC models, 3D brain organoid models, advances in artificially driving neurodegeneration in vivo, and AI/ML methods to...

Are you refining and optimizing your in vivo gene editing delivery strategies for the next generation of gene editors to unlock increased therapeutic efficacy, safety, and cost...

The HER2 space continues to storm ahead of other oncology fields due to the overwhelming success of Enhertu and the continued satisfaction with Herceptin. As we enter 2023, the...

This Fall, the world's longest-standing and most comprehensive TPD meeting, the 6th TPD Summit, returns to Boston in 2023 as the trusted, definitive, end-to-end forum for the...

CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products. As this paradigm...

Those of you who provide care for people with (or at risk of) diabetes know that these patients often have a myriad of comorbidities and complications, and that optimizing...

Despite a challenging 2022 for Gene Therapy developers targeting the CNS, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therapeutics have validated the...

We are excited about the 2023 Boston Lymphatic Symposium, our first in-person clinical symposium since before COVID. The main focus of this year's programming with be...

Returning for the 5th year, the Macrophage-Directed Therapies Summit is your must-attend meeting to deep dive into biological cell plasticity and better understand how to...

Now in 2023 as ESG has transitioned from a value adding business function to a strategic imperative for companies, it is time to take drastic action to integrate your...

There's significant momentum in the clinical and preclinical pipeline for dry AMD, backed by record-breaking investments and acquisitions. This was further demonstrated by the...

Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy...

Eli Lilly's 'triple G' drug retatrutide has galvanized the metabolic field to boost investment in the game-changing obesity drug revolution. With up to 24% weight loss, a new...

The 5th Inflammasome Therapeutics Summit returns to Boston to unite industry pioneers at a critical time as clinical readouts are expected, and a wave of new collaborations hit...

The 4th Annual CRISPR 2.0 Congress will represent the next frontier in the cell and gene therapy landscape. This event will showcase the latest and greatest CRISPR tools that...

The world of internal medicine is changing at a faster pace than ever before. The practicing clinician faces ever-increasing challenges to keep abreast with these changes in...

As neuroscience R and D surges with investment to solve the field's most pressing challenge, access to the brain, the 5th CNS Drug Development Summit will provide an unmissable...

With the number of new clinical ADC targets reaching an all-time high, the 3rd ADC Target Selection Summit returns as the only industry-specific meeting spotlighting the latest...

With drug developers and manufacturers facing closer scrutiny on product quality than ever before, it's time to make the most of evolving process analytical technology to...

The 2nd LNP Immunogenicity and Toxicity Summit is set to unite 100+ PKPD, Immunology, Safety, Toxicology experts from biopharma and academia. This is your opportunity to join...

The field of targeted covalent therapeutics is seeing a surge of activity, with both new and established companies investing heavily in the space. The inaugural Covalent Drug...